{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:57:57Z","timestamp":1792511877469,"version":"4.5.0"},"reference-count":281,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08NS092895"],"award-info":[{"award-number":["K08NS092895"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochirurgie"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.neuchi.2021.04.001","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T22:11:55Z","timestamp":1618438315000},"page":"69-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Brain metastases: An update on the multi-disciplinary approach of clinical management"],"prefix":"10.1016","volume":"68","author":[{"given":"D.K.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6113-8888","authenticated-orcid":false,"given":"H.J.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Kubica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.X.","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"O\u2019Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7024-5164","authenticated-orcid":false,"given":"M.","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuchi.2021.04.001_bib1000","doi-asserted-by":"crossref","DOI":"10.1016\/S0889-8588(05)70269-0","article-title":"Diagnosis and management of brain metastases","volume":"15","author":"Arnold","year":"2001","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1005","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.33459","article-title":"Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies","author":"Bander","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1010","doi-asserted-by":"crossref","first-page":"102083","DOI":"10.1016\/j.ctrv.2020.102083","article-title":"Melanoma brain metastases - Interdisciplinary management recommendations 2020","volume":"89","author":"Gutzmer","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1015","doi-asserted-by":"crossref","first-page":"9953","DOI":"10.2147\/CMAR.S252801","article-title":"Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications","volume":"12","author":"Hadjipanteli","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijrobp.2007.06.074","article-title":"A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database","volume":"70","author":"Sperduto","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.neuchi.2021.04.001_bib1025","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr Oncol Rep"},{"issue":"14","key":"10.1016\/j.neuchi.2021.04.001_bib1035","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.nec.2010.08.007","article-title":"Epidemiology of metastatic brain tumors","volume":"22","author":"Fox","year":"2011","journal-title":"Neurosurg Clin N Am"},{"issue":"6","key":"10.1016\/j.neuchi.2021.04.001_bib1045","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1158\/1078-0432.CCR-06-2478","article-title":"Brain metastases: the HER2 paradigm","volume":"13","author":"Lin","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.neuchi.2021.04.001_bib1050","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","article-title":"Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)","volume":"3","author":"Sperduto","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1055","series-title":"Central Nervous System Metastases","author":"Ahluwalia","year":"2020"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1060","series-title":"Diagnosis and treatment","article-title":"Central nervous system metastases","author":"Ramakrishna","year":"2020"},{"issue":"7586","key":"10.1016\/j.neuchi.2021.04.001_bib1065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massague","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1070","doi-asserted-by":"crossref","first-page":"570","DOI":"10.18632\/oncotarget.2677","article-title":"The landscape of metastatic progression patterns across major human cancers","volume":"6","author":"Budczies","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.neuchi.2021.04.001_bib1075","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.neuchi.2021.04.001_bib1080","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/ncb3011","article-title":"Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S","volume":"16","author":"Sevenich","year":"2014","journal-title":"Nat Cell Biol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/path.4304","article-title":"Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain","volume":"232","author":"Avraham","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1090","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1038\/ncomms7716","article-title":"Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier","volume":"6","author":"Tominaga","year":"2015","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.neuchi.2021.04.001_bib1095","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1091\/mbc.12.9.2699","article-title":"Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells","volume":"12","author":"Voura","year":"2001","journal-title":"Mol Biol Cell"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1349-7006.2004.tb03195.x","article-title":"Increased expression of integrin alpha3beta1 in highly brain metastatic subclone of a human non-small cell lung cancer cell line","volume":"95","author":"Yoshimasu","year":"2004","journal-title":"Cancer Sci"},{"issue":"7604","key":"10.1016\/j.neuchi.2021.04.001_bib1105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature18268","article-title":"Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer","volume":"533","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"7576","key":"10.1016\/j.neuchi.2021.04.001_bib1110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature15376","article-title":"Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth","volume":"527","author":"Zhang","year":"2015","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.neuchi.2021.04.001_bib1115","first-page":"4767","article-title":"Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase","volume":"60","author":"Marchetti","year":"2000","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.4509","article-title":"Astrocytes facilitate melanoma brain metastasis via secretion of IL-23","volume":"236","author":"Klein","year":"2015","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1125","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ijc.31745","article-title":"The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells","volume":"144","author":"Izraely","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1130","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2741\/4573","article-title":"The roles of microglia\/macrophages in tumor progression of brain cancer and metastatic disease","volume":"22","author":"Wu","year":"2017","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1135","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/0008-5472.CAN-18-1805","article-title":"A Blazing Landscape: Neuroinflammation Shapes Brain Metastasis","volume":"79","author":"Doron","year":"2019","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","article-title":"Brain metastases","volume":"5","author":"Achrol","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc.2016.25","article-title":"Targeting metastasis","volume":"16","author":"Steeg","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 4","key":"10.1016\/j.neuchi.2021.04.001_bib1150","first-page":"S245","article-title":"Neuropathology of brain metastases","volume":"4","author":"Pekmezci","year":"2013","journal-title":"Surg Neurol Int"},{"issue":"Suppl 4","key":"10.1016\/j.neuchi.2021.04.001_bib1155","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.4103\/2152-7806.111298","article-title":"Imaging of brain metastases","volume":"4","author":"Fink","year":"2013","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1160","series-title":"Robbins and Cotran pathologic basis of disease","author":"Robbins","year":"2010"},{"issue":"Suppl 2","key":"10.1016\/j.neuchi.2021.04.001_bib1165","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/j.lungcan.2004.07.967","article-title":"Treatment of brain metastases from lung cancer: chemotherapy","volume":"45","author":"Schuette","year":"2004","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.2015.62.0138","article-title":"Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis","volume":"34","author":"Johung","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/JTO.0000000000000069","article-title":"EGFR mutation and brain metastasis in pulmonary adenocarcinomas","volume":"9","author":"Shin","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"13","key":"10.1016\/j.neuchi.2021.04.001_bib1180","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/S1470-2045(15)00013-3","article-title":"Targeting brain metastases in ALK-rearranged non-small-cell lung cancer","volume":"16","author":"Zhang","year":"2015","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib1185","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/annonc\/mdg300","article-title":"Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival","volume":"14","author":"Miller","year":"2003","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib1190","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1634\/theoncologist.12-7-766","article-title":"Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors","volume":"12","author":"Gori","year":"2007","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib1195","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1468-1331.2006.01506.x","article-title":"EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force","volume":"13","author":"Soffietti","year":"2006","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.nrl.0000106922.83090.71","article-title":"Brain metastases","volume":"10","author":"Klos","year":"2004","journal-title":"Neurologist"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1205","first-page":"CD003869","article-title":"Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases","volume":"1","author":"Tsao","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1210","first-page":"335","article-title":"Exploration of symptoms clusters within cancer patients with brain metastases using the Spitzer Quality of Life Index","volume":"18","author":"Hird","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1215","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-12-811161-1.00006-2","article-title":"Brain metastasis: clinical manifestations, symptom management, and palliative care","volume":"149","author":"Noh","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1220","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","article-title":"Brain metastasis","volume":"20","author":"Boire","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1225","first-page":"90","article-title":"Headache characteristics and brain metastases prediction in cancer patients","volume":"15","author":"Argyriou","year":"2006","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"10","key":"10.1016\/j.neuchi.2021.04.001_bib1230","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00415-002-0870-6","article-title":"Management of brain metastases","volume":"249","author":"Soffietti","year":"2002","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11060-004-8094-5","article-title":"Symptomatic management and imaging of brain metastases","volume":"75","author":"Kaal","year":"2005","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1240","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.COC.0000020585.85901.7C","article-title":"Neurocognitive and functional assessment of patients with brain metastases: a pilot study","volume":"26","author":"Herman","year":"2003","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11060-014-1543-x","article-title":"Cognition in patients with newly diagnosed brain metastasis: profiles and implications","volume":"120","author":"Gerstenecker","year":"2014","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1250","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/157339411797642597","article-title":"Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment","volume":"7","author":"Leal","year":"2011","journal-title":"Curr Cancer Ther Rev"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1255","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jocn.2015.11.012","article-title":"Management of leptomeningeal metastases: prognostic factors and associated outcomes","volume":"27","author":"Brower","year":"2016","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cncr.30911","article-title":"Leptomeningeal metastasis from systemic cancer: review and update on management","volume":"124","author":"Wang","year":"2018","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1556-0864(15)31569-0","article-title":"Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?","volume":"1","author":"Shi","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1270","unstructured":"Oncology., N.C.C.N.N.C.P.G.i. https:\/\/www.nccn.org\/professionals\/physician_gls\/ [cit2nd edn020]."},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib1275","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jamaoncol.2018.0813","article-title":"Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non-Small Cell Lung Cancer","volume":"4","author":"Cagney","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000331174","article-title":"Imaging diagnosis of brain metastasis","volume":"25","author":"Barajas","year":"2012","journal-title":"Prog Neurol Surg"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/B978-0-12-811161-1.00007-4","article-title":"Brain metastases: neuroimaging","volume":"149","author":"Pope","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1290","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1148\/radiology.136.3.7403544","article-title":"G.F. Abbott, and J.V. von Sneidern, National Cancer Institute study: evaluation of computed tomography in the diagnosis of intracranial neoplasms. III. Metastatic tumors","volume":"136","author":"Potts","year":"1980","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.neuchi.2021.04.001_bib1295","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/neuonc\/noaa030","article-title":"Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases","volume":"22","author":"Kaufmann","year":"2020","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1300","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/RCT.0b013e318074fd9d","article-title":"Difference in enhancement between spin echo and 3-dimensional fast spoiled gradient recalled acquisition in steady state magnetic resonance imaging of brain metastasis at 3-T magnetic resonance imaging","volume":"32","author":"Furutani","year":"2008","journal-title":"J Comput Assist Tomogr"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib1305","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3174\/ajnr.A1506","volume":"30","author":"Kato","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1310","first-page":"605","article-title":"Improved detection of metastatic melanoma by T2*-weighted imaging","volume":"27","author":"Gaviani","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib1315","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/RCT.0000000000000420","article-title":"Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma","volume":"40","author":"Franceschi","year":"2016","journal-title":"J Comput Assist Tomogr"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1320","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3174\/ajnr.A0903","article-title":"Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density","volume":"29","author":"Noguchi","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib1325","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ejmp.2015.03.010","article-title":"Diffusion Tensor Imaging in brain tumors: A study on gliomas and metastases","volume":"31","author":"Papageorgiou","year":"2015","journal-title":"Phys Med"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib1330","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3174\/ajnr.A5650","article-title":"Diffusion-Weighted Imaging and Diffusion Tensor Imaging for Differentiating High-Grade Glioma from Solitary Brain Metastasis: A Systematic Review and Meta-Analysis","volume":"39","author":"Suh","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"10.1016\/j.neuchi.2021.04.001_bib1335","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11604-014-0342-9","article-title":"contrast dosage for radiologists\u2019 diagnostic performance in detecting brain metastases: a systematic observer study at 3T","volume":"32","author":"Togao","year":"2014","journal-title":"Jpn J Radiol"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1340","first-page":"373","article-title":"The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis","volume":"16","author":"Yuh","year":"1995","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/RLI.0b013e318277b1aa","article-title":"Contrast-enhanced 3-dimensional SPACE versus MP-RAGE for the detection of brain metastases: considerations with a 32-channel head coil","volume":"48","author":"Reichert","year":"2013","journal-title":"Invest Radiol"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1350","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.clinimag.2015.02.010","article-title":"Detection of small brain metastases at 3T: comparing the diagnostic performances of contrast-enhanced T1-weighted SPACE, MPRAGE, and 2D FLASH imaging","volume":"39","author":"Kwak","year":"2015","journal-title":"Clin Imaging"},{"issue":"9","key":"10.1016\/j.neuchi.2021.04.001_bib1355","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00330-007-0599-9","article-title":"Detection of brain metastasis at 3T: comparison among SE, IR-FSE and 3D-GRE sequences","volume":"17","author":"Kakeda","year":"2007","journal-title":"Eur Radiol"},{"issue":"10","key":"10.1016\/j.neuchi.2021.04.001_bib1360","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/02841850802477924","article-title":"Gadolinium-enhanced three-dimensional magnetization-prepared rapid gradient-echo (3D MP-RAGE) imaging is superior to spin-echo imaging in delineating brain metastases","volume":"49","author":"Takeda","year":"2008","journal-title":"Acta Radiol"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1365","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11060-016-2185-y","article-title":"The detectability of brain metastases using contrast-enhanced spin-echo or gradient-echo images: a systematic review and meta-analysis","volume":"129","author":"Suh","year":"2016","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1370","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2463\/mrms.7.13","article-title":"imaging of metastatic brain tumor at 3 tesla: utility of T(1)-weighted SPACE compared with 2D spin echo and 3D gradient echo sequence","volume":"7","author":"Komada","year":"2008","journal-title":"Magn Reson Med Sci"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1375","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/RLI.0b013e3182319704","article-title":"Detection of small metastatic brain tumors: comparison of 3D contrast-enhanced whole-brain black-blood imaging and MP-RAGE imaging","volume":"47","author":"Park","year":"2012","journal-title":"Invest Radiol"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1380","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3174\/ajnr.A2343","article-title":"3D turbo spin-echo sequence with motion-sensitized driven-equilibrium preparation for detection of brain metastases on 3T MR imaging","volume":"32","author":"Nagao","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1385","first-page":"37","article-title":"Comparison of lesion enhancement on spin-echo and gradient-echo images","volume":"15","author":"Chappell","year":"1994","journal-title":"AJNR Am J Neuroradiol"},{"issue":"753","key":"10.1016\/j.neuchi.2021.04.001_bib1390","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1259\/0007-1285-63-753-712","article-title":"Comparison of spin echo T1-weighted and FLASH 90 degrees gadolinium-enhanced magnetic resonance imaging in the detection of cerebral metastases","volume":"63","author":"Cherryman","year":"1990","journal-title":"Br J Radiol"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib1395","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3174\/ajnr.A6096","article-title":"Brain Tumor-Enhancement Visualization and Morphometric Assessment: A Comparison of MPRAGE, SPACE, and VIBE MRI Techniques","volume":"40","author":"Danieli","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"10.1016\/j.neuchi.2021.04.001_bib1400","doi-asserted-by":"crossref","first-page":"e0163081","DOI":"10.1371\/journal.pone.0163081","article-title":"Detection of Leptomeningeal Metastasis by Contrast-Enhanced 3D T1-SPACE: Comparison with 2D FLAIR and Contrast-Enhanced 2D T1-Weighted Images","volume":"11","author":"Gil","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1405","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1148\/rg.272065155","article-title":"Patterns of contrast enhancement in the brain and meninges","volume":"27","author":"Smirniotopoulos","year":"2007","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1410","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.crad.2003.08.006","article-title":"In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases","volume":"59","author":"Fan","year":"2004","journal-title":"Clin Radiol"},{"issue":"8","key":"10.1016\/j.neuchi.2021.04.001_bib1415","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00234-004-1246-7","article-title":"Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings","volume":"46","author":"Chiang","year":"2004","journal-title":"Neuroradiology"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1420","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3413\/Nukmed-0338-10-07","article-title":"Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET\/CT for diagnosis in the initial staging","volume":"50","author":"Kr\u00fcger","year":"2011","journal-title":"Nuklearmedizin"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1425","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1148\/radiol.2261010920","article-title":"Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy","volume":"226","author":"Rohren","year":"2003","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1430","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jmri.21031","article-title":"Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients","volume":"26","author":"Ohno","year":"2007","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib1435","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/neuonc\/noz003","article-title":"PET imaging in patients with brain metastasis-report of the RANO\/PET group","volume":"21","author":"Galldiks","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1440","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fonc.2018.00161","article-title":"Mechanisms and Therapy for Cancer Metastasis to the Brain","volume":"8","author":"Franchino","year":"2018","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.neuchi.2021.04.001_bib1445","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ana.410070606","article-title":"J.H. Kim, and J.B. Posner, Radiation therapy for brain metastases","volume":"7","author":"Cairncross","year":"1980","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neuchi.2021.04.001_bib1450","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0305-7372(03)00105-1","article-title":"The management of brain metastases","volume":"29","author":"Patchell","year":"2003","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1455","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/neuonc\/now241","article-title":"Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)","volume":"19","author":"Soffietti","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1460","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fonc.2017.00230","article-title":"Genetic Characterization of Brain Metastases in the Era of Targeted Therapy","volume":"7","author":"Han","year":"2017","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.neuchi.2021.04.001_bib1465","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1470","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00701-012-1606-8","article-title":"Retrospective study of 127 surgically treated patients with multiple brain metastases: indication, prognostic factors, and outcome","volume":"155","author":"Schackert","year":"2013","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1475","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/jns.1993.79.2.0210","article-title":"Surgical treatment of multiple brain metastases","volume":"79","author":"Bindal","year":"1993","journal-title":"J Neurosurg"},{"issue":"10","key":"10.1016\/j.neuchi.2021.04.001_bib1480","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00701-013-1821-y","article-title":"Surgery of recurrent brain metastases: retrospective analysis of 67 patients","volume":"155","author":"Schackert","year":"2013","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1485","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0360-3016(94)90558-4","article-title":"The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age","volume":"29","author":"Noordijk","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1490","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3171\/2016.2.JNS152855","article-title":"Functional approach using intraoperative brain mapping and neurophysiological monitoring for the surgical treatment of brain metastases in the central region","volume":"126","author":"Sanmillan","year":"2017","journal-title":"J Neurosurg"},{"issue":"10","key":"10.1016\/j.neuchi.2021.04.001_bib1495","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/lsm.21138","article-title":"Laser thermal therapy: real-time MRI-guided and computer-controlled procedures for metastatic brain tumors","volume":"43","author":"Carpentier","year":"2011","journal-title":"Lasers Surg Med"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1500","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s13311-017-0520-4","article-title":"A.M. Sonabend, and J.N. Bruce, Convection-Enhanced Delivery","volume":"14","author":"Mehta","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"37","key":"10.1016\/j.neuchi.2021.04.001_bib1505","doi-asserted-by":"crossref","first-page":"E8717","DOI":"10.1073\/pnas.1807105115","article-title":"Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption","volume":"115","author":"Arvanitis","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1510","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","author":"Suh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1515","doi-asserted-by":"crossref","first-page":"E152","DOI":"10.1093\/neuros\/nyy542","article-title":"Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Surgery in the Management of Adults With Metastatic Brain Tumors","volume":"84","author":"Nahed","year":"2019","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib1520","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3171\/2014.9.JNS13939","article-title":"Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis","volume":"122","author":"Patel","year":"2015","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1525","series-title":"Perez & Brady's Principles and Practice of Radiation Oncology","article-title":"Principles and practice of radiation oncology","author":"Halperin","year":"2004"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1530","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/neuonc\/nou284","article-title":"The biology of radiosurgery and its clinical applications for brain tumors","volume":"17","author":"Kondziolka","year":"2015","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.neuchi.2021.04.001_bib1535","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC.3): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.neuchi.2021.04.001_bib1540","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.neuchi.2021.04.001_bib1545","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1200\/JOP.2016.012922","article-title":"Stereotactic Radiosurgery for Treatment of Brain Metastases","volume":"12","author":"Badiyan","year":"2016","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1550","article-title":"Preoperative Vs Postoperative Radiosurgery For Resected Brain Metastases: A Review","author":"Prabhu","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1555","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.wneu.2015.12.003","article-title":"From Patchell to Brown: An Evidence-Based Evolution of the Role of Radiotherapy on the Management of Brain Metastases","volume":"85","author":"Flores","year":"2016","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1560","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11060-019-03153-8","article-title":"Tumor control and survival in patients with ten or more brain metastases treated with stereotactic radiosurgery: a retrospective analysis","volume":"143","author":"Ehrlich","year":"2019","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1565","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1570","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.neuchi.2021.04.001_bib1575","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3171\/jns.2006.104.6.907","article-title":"Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin","volume":"104","author":"Vogelbaum","year":"2006","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1580","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1227\/NEU.0b013e318208f58e","article-title":"Local control of newly diagnosed and distally recurrent, low-volume brain metastases with fixed-dose (20 gy) gamma knife radiosurgery","volume":"68","author":"Elliott","year":"2011","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1585","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1006110631704","article-title":"Prognostic factor analysis for multiple brain metastases after gamma knife radiosurgery: results in 97 patients","volume":"42","author":"Schoeggl","year":"1999","journal-title":"J Neurooncol"},{"issue":"5 Suppl","key":"10.1016\/j.neuchi.2021.04.001_bib1590","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3171\/jns.2002.97.supplement_5.0499","article-title":"Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery","volume":"97","author":"Petrovich","year":"2002","journal-title":"J Neurosurg"},{"issue":"10","key":"10.1016\/j.neuchi.2021.04.001_bib1595","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jocn.2015.05.019","article-title":"Stereotactic radiosurgery for large brain metastases","volume":"22","author":"Ebner","year":"2015","journal-title":"J Clin Neurosci"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1600","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1605","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0360-3016(95)02106-X","article-title":"Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05)","volume":"34","author":"Shaw","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1610","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/neuonc\/noy159","article-title":"Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose","volume":"21","author":"Moraes","year":"2019","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1615","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/02688690902755613","article-title":"Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis","volume":"23","author":"Molenaar","year":"2009","journal-title":"Br J Neurosurg"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1620","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3171\/2016.3.JNS153014","article-title":"Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases","volume":"126","author":"Mohammadi","year":"2017","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib1625","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ijrobp.2007.03.048","article-title":"Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone","volume":"68","author":"Aoyama","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1630","first-page":"1","article-title":"Comparison of treatment results between 3- and 2-stage Gamma Knife radiosurgery for large brain metastases: a retrospective multi-institutional study","author":"Serizawa","year":"2018","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1635","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fonc.2018.00379","article-title":"Hypofractionated Radiation Therapy for Large Brain Metastases","volume":"8","author":"Masucci","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1640","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-717X-7-36","article-title":"Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters","volume":"7","author":"Jiang","year":"2012","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1645","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11060-014-1388-3","article-title":"Fractionated stereotactic radiosurgery for patients with brain metastases","volume":"117","author":"Minniti","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1650","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13014-016-0653-3","article-title":"Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection","volume":"11","author":"Navarria","year":"2016","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1655","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.canrad.2013.12.003","article-title":"Stereotactic radiotherapy for large solitary brain metastases","volume":"18","author":"Feuvret","year":"2014","journal-title":"Cancer Radiother"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1660","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3171\/2017.3.JNS162532","article-title":"Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases \u2265 2 cm","volume":"129","author":"Angelov","year":"2018","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib1665","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ijrobp.2008.10.035","article-title":"Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors","volume":"74","author":"Higuchi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1670","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/neuros\/nyx355","article-title":"Staged Stereotactic Radiosurgery for Large Brain Metastases: Local Control and Clinical Outcomes of a One-Two Punch Technique","volume":"83","author":"Dohm","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1675","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.radonc.2019.09.019","article-title":"Dose response and architecture in volume staged radiosurgery for large arteriovenous malformations: A multi-institutional study","volume":"144","author":"Seymour","year":"2020","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib1680","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/cjn.2015.55","article-title":"Stereotactic Radiosurgery for Metastases in Eloquent Central Brain Locations","volume":"42","author":"Hsu","year":"2015","journal-title":"Can J Neurol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.neuchi.2021.04.001_bib1685","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000098784","article-title":"Radiation sensitivity of visual and oculomotor pathways","volume":"64","author":"Leber","year":"1995","journal-title":"Stereotact Funct Neurosurg"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1690","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3171\/jns.1998.88.1.0043","article-title":"Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery","volume":"88","author":"Leber","year":"1998","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib1695","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0360-3016(97)00507-5","article-title":"Analyses of neuro-otological complications after radiosurgery for acoustic neurinomas","volume":"39","author":"Ito","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib1700","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0360-3016(02)04380-8","article-title":"A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery","volume":"55","author":"Stafford","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1705","article-title":"Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways","author":"Milano","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1710","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1227\/01.NEU.0000367554.96981.26","article-title":"Tolerance of the optic apparatus in single-fraction irradiation using stereotactic radiosurgery: evaluation in 100 patients with craniopharyngioma","volume":"66","author":"Hasegawa","year":"2010","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1715","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0360-3016(93)90230-S","article-title":"Tolerance of cranial nerves of the cavernous sinus to radiosurgery","volume":"27","author":"Tishler","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1720","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3171\/sup.2005.102.s_supplement.0195","article-title":"Radiosurgery of vestibular schwannomas: summary of experience in 829 cases","volume":"102Suppl","author":"Lunsford","year":"2005","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1725","first-page":"71","article-title":"Preservation of cranial nerve function following Gamma Knife radiosurgery for benign skull base meningiomas: experience in 121 patients with follow-up of 5 to 9.8 years","volume":"84","author":"Eustacchio","year":"2002","journal-title":"Acta Neurochir Suppl"},{"issue":"10","key":"10.1016\/j.neuchi.2021.04.001_bib1730","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/jnnp.2004.049213","article-title":"Long term experience of gamma knife radiosurgery for benign skull base meningiomas","volume":"76","author":"Kreil","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5 Suppl","key":"10.1016\/j.neuchi.2021.04.001_bib1735","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3171\/jns.2002.97.supplement_5.0456","article-title":"Gamma knife radiosurgery for jugular foramen schwannomas","volume":"97","author":"Zhang","year":"2002","journal-title":"J Neurosurg"},{"issue":"11","key":"10.1016\/j.neuchi.2021.04.001_bib1740","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1745","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.coc.0000143017.69880.04","article-title":"Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brain","volume":"28","author":"Schomas","year":"2005","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1750","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1634\/theoncologist.2012-0316","article-title":"Recursive partitioning analysis for the prediction of stereotactic radiosurgery brain metastases lesion control","volume":"18","author":"Rodrigues","year":"2013","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1755","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2004-818511","article-title":"Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma","volume":"47","author":"Muacevic","year":"2004","journal-title":"Minim Invasive Neurosurg"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1760","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3171\/jns.2006.105.4.555","article-title":"Gamma knife surgery for metastatic brain tumors from renal cell carcinoma","volume":"105","author":"Shuto","year":"2006","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1765","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3171\/jns.2002.97.4.0785","article-title":"Repeated gamma knife surgery for multiple brain metastases from renal cell carcinoma","volume":"97","author":"Wowra","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1770","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/s002800051092","article-title":"F.G. Barker, and P.H. Chapman, Role of radiosurgery in the management of central nervous system metastases","volume":"43Suppl","author":"Loeffler","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1775","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3171\/sup.2005.102.s_supplement.0075","article-title":"Analysis of long-term outcomes and prognostic factors in patients with non-small cell lung cancer brain metastases treated by gamma knife radiosurgery","volume":"102Suppl","author":"Gerosa","year":"2005","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.neuchi.2021.04.001_bib1780","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3171\/jns.2002.97.6.1276","article-title":"Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control","volume":"97","author":"Sheehan","year":"2002","journal-title":"J Neurosurg"},{"issue":"9","key":"10.1016\/j.neuchi.2021.04.001_bib1785","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00066-004-1299-x","article-title":"Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery","volume":"180","author":"Combs","year":"2004","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1790","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijrobp.2016.09.043","article-title":"Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases","volume":"97","author":"Gorovets","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1795","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11060-017-2588-4","article-title":"Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram","volume":"135","author":"Ayala-Peacock","year":"2017","journal-title":"J Neurooncol"},{"issue":"9","key":"10.1016\/j.neuchi.2021.04.001_bib1800","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/neuonc\/nou018","article-title":"A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy","volume":"16","author":"Ayala-Peacock","year":"2014","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1805","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1810","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijrobp.2016.06.009","article-title":"Stereotactic Radiosurgery for Brainstem Metastases: An International Cooperative Study to Define Response and Toxicity","volume":"96","author":"Trifiletti","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1815","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2005.12.002","article-title":"Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy","volume":"65","author":"Ruben","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1820","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3171\/2014.10.JNS141610","article-title":"Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors","volume":"123","author":"Sneed","year":"2015","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1825","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2018.10.038","article-title":"Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials","volume":"103","author":"Lehrer","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1830","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ijrobp.2016.03.013","article-title":"Single-Fraction Versus Multifraction (3\u00d79\u00a0Gy) Stereotactic Radiosurgery for Large (> 2\u00a0cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis","volume":"95","author":"Minniti","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.neuchi.2021.04.001_bib1835","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3171\/2017.7.JNS171286","article-title":"Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects","volume":"129","author":"Diao","year":"2018","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1840","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clineuro.2019.02.010","article-title":"Symptomatic radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapy","volume":"179","author":"Weingarten","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1845","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3171\/2015.6.JNS142763","article-title":"Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?","volume":"125","author":"Colaco","year":"2016","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1850","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2017.09.010","article-title":"Diagnosis and treatment options for sequelae following radiation treatment of brain tumors","volume":"163","author":"Mehta","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1855","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00066-019-01521-x","article-title":"Bevacizumab as a\u00a0treatment option for radiation necrosis after cranial radiation therapy: a\u00a0retrospective monocentric analysis","volume":"196","author":"Bodensohn","year":"2020","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1860","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11060-016-2219-5","article-title":"Treatment of pediatric cerebral radiation necrosis: a systematic review","volume":"130","author":"Drezner","year":"2016","journal-title":"J Neurooncol"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib1865","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2018.04.068","article-title":"Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial","volume":"101","author":"Xu","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1870","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12943-019-0950-1","article-title":"Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues","volume":"18","author":"Zhuang","year":"2019","journal-title":"Mol Cancer"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib1875","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system","volume":"79","author":"Levin","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1880","doi-asserted-by":"crossref","first-page":"24","DOI":"10.28920\/dhm47.1.24-32","article-title":"Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment","volume":"47","author":"Mathieu","year":"2017","journal-title":"Diving Hyperb Med"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1885","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3171\/2017.11.JNS171273","article-title":"Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis","volume":"130","author":"Ahluwalia","year":"2018","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1890","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11060-020-03570-0","article-title":"Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases","volume":"148","author":"Sujijantarat","year":"2020","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1895","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ijrobp.2013.07.034","article-title":"Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases","volume":"87","author":"Atalar","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1900","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11060-014-1539-6","article-title":"Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery","volume":"120","author":"Huang","year":"2014","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1905","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijrobp.2015.11.022","article-title":"Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery","volume":"94","author":"Johnson","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1910","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3171\/2014.6.GKS14708","article-title":"Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis","volume":"121Suppl","author":"Ojerholm","year":"2014","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1915","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1227\/NEU.0000000000001096","article-title":"Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis","volume":"79","author":"Patel","year":"2016","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1920","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s11060-014-1601-4","article-title":"Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone","volume":"120","author":"Patel","year":"2014","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1925","doi-asserted-by":"crossref","DOI":"10.1016\/j.nec.2010.08.006","article-title":"Leptomeningeal disease","volume":"22","author":"Groves","year":"2011","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.neuchi.2021.04.001_bib1930","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3389\/fneur.2018.00959","article-title":"Preoperative Stereotactic Radiosurgery for Brain Metastases","volume":"9","author":"Routman","year":"2018","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib1935","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0360-3016(00)00527-7","article-title":"Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases","volume":"47","author":"Chidel","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1940","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijrobp.2003.10.009","article-title":"Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy","volume":"59","author":"Shehata","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"21","key":"10.1016\/j.neuchi.2021.04.001_bib1945","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib1950","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ijrobp.2013.10.007","article-title":"Individual Patient Data (IPD) Meta-Analysis of Randomized Controlled Trials (RCT) Comparing Stereotactic Radiosurgery Alone to SRS Plus Whole Brain Radiation Therapy in Patients With Brain Metastasis","volume":"87","author":"Sahgal","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib1955","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"Soffietti","year":"2013","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.neuchi.2021.04.001_bib1960","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","article-title":"Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial","volume":"280","author":"Patchell","year":"1998","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib1965","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2016.10.005","article-title":"Stereotactic radiotherapy of the tumor bed compared to whole brain radiotherapy after surgery of single brain metastasis: Results from a randomized trial","volume":"121","author":"K\u0119pka","year":"2016","journal-title":"Radiother Oncol"},{"issue":"9422","key":"10.1016\/j.neuchi.2021.04.001_bib1970","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.neuchi.2021.04.001_bib1975","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial","volume":"314","author":"Stupp","year":"2015","journal-title":"JAMA"},{"issue":"10055","key":"10.1016\/j.neuchi.2021.04.001_bib1980","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0140-6736(16)30825-X","volume":"388","author":"Mulvenna","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib1985","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0360-3016(97)00341-6","article-title":"A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104","volume":"39","author":"Murray","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.neuchi.2021.04.001_bib1990","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/0360-3016(81)90184-X","article-title":"Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group","volume":"7","author":"Borgelt","year":"1981","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib1995","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0360-3016(81)90005-5","article-title":"The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group","volume":"7","author":"Kurtz","year":"1981","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib2000","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0360-3016(91)90137-S","article-title":"A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)","volume":"20","author":"Komarnicky","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib2005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0360-3016(95)00168-X","article-title":"Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05","volume":"33","author":"Phillips","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.neuchi.2021.04.001_bib2010","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol"},{"issue":"34","key":"10.1016\/j.neuchi.2021.04.001_bib2015","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial","volume":"32","author":"Gondi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib2020","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noaa092","article-title":"Phase II Trial of Hippocampal-Sparing Whole Brain Irradiation with Simultaneous Integrated Boost (HSIB-WBRT) for Metastatic Cancer","author":"Westover","year":"2020","journal-title":"Neuro Oncol"},{"issue":"10","key":"10.1016\/j.neuchi.2021.04.001_bib2025","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib2030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/156800912799277511","article-title":"The blood-brain barrier: its influence in the treatment of brain tumors metastases","volume":"12","author":"Fortin","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"issue":"23","key":"10.1016\/j.neuchi.2021.04.001_bib2035","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1158\/1078-0432.CCR-10-1564","article-title":"Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer","volume":"16","author":"Lockman","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"30","key":"10.1016\/j.neuchi.2021.04.001_bib2040","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1200\/JCO.2015.60.9503","article-title":"Treatment of Brain Metastases","volume":"33","author":"Lin","year":"2015","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.neuchi.2021.04.001_bib2045","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1704795","article-title":"Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer","volume":"377","author":"Peters","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib2050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1470-2045(12)70432-1","article-title":"Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study","volume":"14","author":"Bachelot","year":"2013","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.neuchi.2021.04.001_bib2055","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1470-2045(12)70431-X","article-title":"Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial","volume":"13","author":"Long","year":"2012","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib2060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ejca.2013.11.002","article-title":"Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study","volume":"50","author":"Dummer","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.neuchi.2021.04.001_bib2065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11060-020-03615-4","article-title":"Intracranial disease control for EGFR-mutant and ALK-rearranged lung cancer with large volume or symptomatic brain metastases","volume":"149","author":"Dutta","year":"2020","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib2070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.lungcan.2008.12.011","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis","volume":"65","author":"Kim","year":"2009","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib2075","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1183\/09031936.00195609","article-title":"Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation","volume":"37","author":"Porta","year":"2011","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib2080","doi-asserted-by":"crossref","first-page":"dju151","DOI":"10.1093\/jnci\/dju151","article-title":"Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastases","volume":"106","author":"Lee","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib2085","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.cllc.2017.01.013","article-title":"Pulsatile Erlotinib in EGFR-Positive Non-Small-Cell Lung Cancer Patients With Leptomeningeal and Brain Metastases: Review of the Literature","volume":"18","author":"How","year":"2017","journal-title":"Clin Lung Cancer"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib2090","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1200\/JCO.2011.40.1174","article-title":"trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer","volume":"31","author":"Welsh","year":"2013","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib2095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa1612674","article-title":"Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer","volume":"376","author":"Mok","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib2100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuchi.2021.04.001_bib2105","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1200\/EDBK_100006","article-title":"Targeted Therapy in Brain Metastases: Ready for Primetime?","volume":"35","author":"Venur","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"10089","key":"10.1016\/j.neuchi.2021.04.001_bib2110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(17)30565-2","article-title":"Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial","volume":"390","author":"Hida","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib2115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/JTO.0000000000000455","article-title":"Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinib","volume":"10","author":"Gainor","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"9","key":"10.1016\/j.neuchi.2021.04.001_bib2120","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1704795","article-title":"Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer","volume":"377","author":"Peters","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.neuchi.2021.04.001_bib2125","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1200\/JCO.2016.71.5904","article-title":"Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial","volume":"35","author":"Kim","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib2130","doi-asserted-by":"crossref","DOI":"10.1111\/cas.14576","article-title":"Lorlatinib in previously treated anaplastic lymphoma kinase-rearranged non-small cell lung cancer: Japanese subgroup analysis of a global study","author":"Seto","year":"2020","journal-title":"Cancer Sci"},{"issue":"12","key":"10.1016\/j.neuchi.2021.04.001_bib2135","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S1470-2045(19)30655-2","article-title":"Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial","volume":"20","author":"Shaw","year":"2019","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.neuchi.2021.04.001_bib2140","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S1470-2045(18)30649-1","article-title":"Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study","volume":"19","author":"Solomon","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib2145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/annonc\/mdu486","article-title":"Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA","volume":"26","author":"Krop","year":"2015","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib2150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1470-2045(12)70432-1","article-title":"Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study","volume":"14","author":"Bachelot","year":"2013","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.neuchi.2021.04.001_bib2155","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2007.12.3588","article-title":"trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer","volume":"26","author":"Lin","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib2160","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1158\/1078-0432.CCR-08-1080","article-title":"Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer","volume":"15","author":"Lin","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.neuchi.2021.04.001_bib2165","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1200\/JCO.18.01511","article-title":"TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases","volume":"37","author":"Freedman","year":"2019","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib2170","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJMoa1914609","article-title":"Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer","volume":"382","author":"Murthy","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.neuchi.2021.04.001_bib2175","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/jamaoncol.2018.1812","article-title":"Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2\/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial","volume":"4","author":"Borges","year":"2018","journal-title":"JAMA Oncol"},{"issue":"21","key":"10.1016\/j.neuchi.2021.04.001_bib2180","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/cncr.32375","article-title":"The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis","volume":"125","author":"Rulli","year":"2019","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib2185","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/annonc\/mdw641","article-title":"Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study","volume":"28","author":"McArthur","year":"2017","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib2190","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","article-title":"Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial","volume":"18","author":"Davies","year":"2017","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib2195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/cncr.32547","article-title":"Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: a case series","volume":"126","author":"Holbrook","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib2200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/CMR.0000000000000527","article-title":"Clinical experience with combination BRAF\/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study","volume":"29","author":"Drago","year":"2019","journal-title":"Melanoma Res"},{"issue":"12","key":"10.1016\/j.neuchi.2021.04.001_bib2205","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00066-014-0698-x","article-title":"Increased skin and mucosal toxicity in the combination of vemurafenib with radiation therapy","volume":"190","author":"Merten","year":"2014","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib2210","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ijrobp.2016.01.038","article-title":"Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG)","volume":"95","author":"Anker","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib2215","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamadermatol.2013.4200","article-title":"Vemurafenib and radiosensitization","volume":"149","author":"Boussemart","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"13","key":"10.1016\/j.neuchi.2021.04.001_bib2220","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1200\/JCO.2012.44.4265","article-title":"Serious skin toxicity with the combination of BRAF inhibitors and radiotherapy","volume":"31","author":"Satzger","year":"2013","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.neuchi.2021.04.001_bib2225","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1215\/15228517-2008-062","article-title":"Prognostic factors and outcomes in patients with leptomeningeal melanomatosis","volume":"10","author":"Harstad","year":"2008","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.neuchi.2021.04.001_bib2230","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib2235","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib2240","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(12)70090-6","article-title":"Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial","volume":"13","author":"Margolin","year":"2012","journal-title":"Lancet Oncol"},{"issue":"15_suppl","key":"10.1016\/j.neuchi.2021.04.001_bib2245","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1200\/JCO.2017.35.15_suppl.9507","article-title":"Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204","volume":"35","author":"Tawbi","year":"2017","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.001_bib2250","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","article-title":"Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial","volume":"17","author":"Goldberg","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib2255","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.18.00204","article-title":"Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial","volume":"37","author":"Kluger","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib2260","first-page":"1","article-title":"Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non-small cell lung cancer to the brain: a matched cohort study","author":"Shepard","year":"2019","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib2265","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jtho.2018.01.012","article-title":"Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non-Small Cell Lung Cancer","volume":"13","author":"Hubbeling","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib2270","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1470-2045(20)30111-X","article-title":"Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial","volume":"21","author":"Goldberg","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib2275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lungcan.2018.12.025","article-title":"Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer","volume":"129","author":"Crin\u00f2","year":"2019","journal-title":"Lung Cancer"},{"issue":"23","key":"10.1016\/j.neuchi.2021.04.001_bib2280","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.18.02218","article-title":"Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study","volume":"37","author":"Flippot","year":"2019","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.neuchi.2021.04.001_bib2285","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/neuonc\/noz046","article-title":"The Impact of Sequencing PD-1\/PD-L1 Inhibitors and Stereotactic Radiosurgery for Patients with Brain Metastasis","volume":"21","author":"Kotecha","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib2290","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40425-015-0095-8","article-title":"Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review","volume":"3","author":"Schoenfeld","year":"2015","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib2295","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijrobp.2018.02.175","article-title":"Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases","volume":"101","author":"Schapira","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.neuchi.2021.04.001_bib2300","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/cam4.140","article-title":"Ipilimumab and radiation therapy for melanoma brain metastases","volume":"2","author":"Silk","year":"2013","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib2305","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3171\/2012.5.JNS111929","article-title":"Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival","volume":"117","author":"Knisely","year":"2012","journal-title":"J Neurosurg"},{"issue":"1.","key":"10.1016\/j.neuchi.2021.04.001_bib2310","article-title":"Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients","volume":"8","author":"Amaral","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib2315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cam4.315","article-title":"Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery","volume":"4","author":"Tazi","year":"2015","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.neuchi.2021.04.001_bib2320","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1002\/cncr.23821","article-title":"Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy","volume":"113","author":"Chao","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib2325","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijrobp.2013.10.003","article-title":"Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection","volume":"88","author":"Kurtz","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib2330","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11060-015-1937-4","article-title":"Repeated stereotactic radiosurgery for patients with progressive brain metastases","volume":"126","author":"Minniti","year":"2016","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib2335","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijrobp.2011.06.1987","article-title":"Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy","volume":"83","author":"Caballero","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.001_bib2340","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1097-0142(19950901)76:5<765::AID-CNCR2820760509>3.0.CO;2-E","article-title":"The treatment of patients with recurrent brain metastases. A retrospective analysis of 109 patients with nonsmall cell lung cancer","volume":"76","author":"Arbit","year":"1995","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib2345","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3171\/jns.1995.83.4.0600","article-title":"Reoperation for recurrent metastatic brain tumors","volume":"83","author":"Bindal","year":"1995","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib2350","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.ijrobp.2011.03.020","article-title":"Outcomes after whole brain reirradiation in patients with brain metastases","volume":"82","author":"Son","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3.","key":"10.1016\/j.neuchi.2021.04.001_bib2355","article-title":"Association of Steroids use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis","volume":"12","author":"Petrelli","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.001_bib2360","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-009-0069-0","article-title":"Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy","volume":"98","author":"Maschio","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.neuchi.2021.04.001_bib2365","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.2147\/NDT.S87109","article-title":"Palliative whole-brain radiotherapy and health- related quality of life for patients with brain metastasis in cancer","volume":"11","author":"Gao","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib2370","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0360-3016(00)00547-2","article-title":"Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases","volume":"47","author":"Gaspar","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib2375","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.001_bib2380","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ijrobp.2017.06.2454","article-title":"Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)","volume":"99","author":"Sperduto","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib2385","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/neuros\/nyx380","article-title":"Cumulative Intracranial Tumor Volume Augments the Prognostic Value of Diagnosis-Specific Graded Prognostic Assessment Model for Survival in Patients with Melanoma Cerebral Metastases","volume":"83","author":"Hirshman","year":"2018","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.001_bib2390","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1227\/NEU.0000000000001123","article-title":"Cumulative Intracranial Tumor Volume (CITV) Enhances the Prognostic Value of the Lung-Specific Graded Prognostic Assessment (GPA) Model","volume":"79","author":"Marcus","year":"2016","journal-title":"Neurosurgery"},{"issue":"11","key":"10.1016\/j.neuchi.2021.04.001_bib2395","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.001_bib2400","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0360-3016(01)01676-5","article-title":"Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04","volume":"51","author":"Regine","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Neurochirurgie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028377021000990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028377021000990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:33:02Z","timestamp":1758436382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028377021000990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":281,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0028377021000990"],"URL":"https:\/\/doi.org\/10.1016\/j.neuchi.2021.04.001","relation":{},"ISSN":["0028-3770"],"issn-type":[{"value":"0028-3770","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain metastases: An update on the multi-disciplinary approach of clinical management","name":"articletitle","label":"Article Title"},{"value":"Neurochirurgie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuchi.2021.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}